FINWIRES · TerminalLIVE
FINWIRES

調査速報:CFRAはEntegris, Inc.の株式に対する売り推奨を維持。

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。目標株価を19ドル引き上げ、114ドルとします。これは、2026年のEPS予想(3.55ドル)の32倍に相当し、同業他社と同水準ですが、ENTGの過去3年間の平均PER(約34倍)を下回っています。これは、主流市場の低迷と競争激化がAIの上昇余地を相殺しているためです。2026年のEPS予想を0.17ドル引き上げ、3.55ドルとします。また、2027年のEPS予想を0.04ドル引き上げ、4.64ドルとします。ENTGの2027年および2028年のEPS予想は、同社の2026年の新規ファブ建設予測の改善(前四半期の中一桁台から現在は高一桁台に上昇)に伴い、徐々に上方修正されています。関連収益は、通常9~18ヶ月遅れて計上されます。とはいえ、短期的な業績は、メモリ不足による課題に直面するであろう主流事業(売上高の30%)の影響を受けやすく、ENTGのAI事業への全体的なエクスポージャーは、同業他社と比較してかなり限定的(主にファブ全体の活動と建設開始に基づく)と見ており、特に最近の業績不振を考慮すると、より高い評価を正当化するのは困難です。中国での売上高は2026年第1四半期に前年同期比4%減(第1四半期全体の18%)となり、現地での競争激化が予想されることから、依然としてリスク要因となっています。

Related Articles

Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Sba Communications Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price $20 to $250, applying an EV/EBITDA multiple of 20.0x our 2026 estimate, a premium to its three-year average multiple of 19.8x, reflecting improving international growth. We increase our 2026 AFFO estimate by $0.35 to $12.30 and decrease 2027 by $0.22 to $13.00. SBAC saw improvement in Q1 from domestic carrier spending picking up despite known churn-related headwinds, which management believes will peak in 2026. Recent rumors have emerged identifying SBAC as a buyout candidate from major infrastructure funds, specifically KKR & Co (KKR 104 ****) and Brookfield Asset Management (BAM 48 ****). Management offered no comment, but takeover interest was a question that came up on the call. We continue to believe Millicom integration will drive ROIC lower this year before expanding in 2027 as profitability increases. Central America has potential for long-term growth and new tower investment with attractive risk-adjusted returns, in our view.

$SBAC
Research

Research Alert: CFRA Retains Hold View On Shares Of Regency Centers Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target by $2 to $83, 17.1x our 2026 FFO estimate, a premium to both the three-year average (15.6x) to reflect strength in grocery-anchored shopping centers. We increase our 2026 FFO view by $0.06 to $4.86 and increase 2027 by $0.05 to $4.99. REG continues to generate high re-leasing spreads with seasonally elevated occupancy. The current signed-not-occupied pipeline is a tailwind with $42 million of incremental rental growth as tenants move-in. Management believes it will have $1B in project starts over the next three years creating an internal growth story to monitor. Current development pipeline exceeds $600 million with blended returns over 9%. We view REG as fairly valued with lower multiple grocery anchored names providing similar growth with stronger geographic footprints, in our view.

$REG
Research

Research Alert: CFRA Maintains Sell Rating On Shares Of Entegris, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $19 to $114, 32x our 2026 EPS view ($3.55), near peers but below ENTG's three-year average multiple (~34x) as mainstream weakness and rising competition offset AI upside. We lift our 2026 EPS view by $0.17 to $3.55 and raise 2027's by $0.04 to $4.64. Our 2027/2028 view keeps creeping up for ENTG along with the company's improving new fab construction forecast for 2026 (now to high-single digits vs. a mid-single-digit view last quarter), with related revenues generally following on a nine to 18 month lag. Still, near-term results remain vulnerable to mainstream activity (30% of sales) that should face challenges from the memory shortage, and we view ENTG's overall AI exposure as fairly limited (based largely around overall fab activity and construction starts) compared to peers, making a more premium valuation harder to justify, especially given recent underperformance. China sales fell 4% Y/Y in Q1 2026 (18% of Q1 total) and remain a risk given our view of intensifying local competition.

$ENTG